kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the ABUS dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for ABUS.

ABUS

Arbutus Biopharma Corp
Healthcare · Biotechnology
$115.89 sample
-1.81 (-1.54%) 1D
☆ Watch
Market cap
$711.1B
Price as of
2026-10-25
Latest filing
8-K · 2026-09-17
Alerts
8
Price$115.89 +6.11% 3M daily closessample
119.36107.20
2026-07-282026-08-192026-09-102026-10-012026-10-23
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 20INSInsider buy: General Counsel
  • Oct 13INSInsider buy: Director
  • Oct 05INSInsider sell: Director
  • Sep 25INSInsider sell: EVP, Operations
  • Sep 17SECDEF 14A filed
  • Sep 14INSInsider sell: Director
  • Sep 09SEC8-K filed: material event
  • Aug 31SEC8-K filed: material event
Sign up to see the real ABUS record →

Company facts

SEC EDGAR registration
Name
Arbutus Biopharma Corp
Sector
Healthcare
Industry
Biotechnology
Smart-money score
+4sample, -100 to +100
Reporting currency
USD

Who is positioning in ABUS

sample
Insiders
35 insider transactions over 90 days, net selling, $179.9M
Congress
2 members traded over 90 days
Institutions · 13F
14 funds hold $12.1B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$34.6B +19.2% y/y
Q4 2024Q3 2026
Inventory$21.0B +11.6% y/y
Q4 2024Q3 2026
Accounts receivable$15.7B +11.5% y/y
Q4 2024Q3 2026
Total debt$40.8B +11.7% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$655.0B +5.0% 3M
Sample peer B
$381.8B +4.5% 3M
Sample peer C
$607.3B +1.8% 3M
Sample peer D
$103.9B -9.8% 3M
Sample peer E
$542.6B +8.2% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not ABUS's real figure. Nothing here is investment advice.